Cetera Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
Cetera Advisors's EXAS Position: Q1 2024 in Review
Cetera Advisors increased its Exact Sciences (EXAS) stake by 519% in Q1 2024, buying an estimated $2.08M and bringing the position to 39,147 shares worth $2.7M. The position accounts for 0.02% of the portfolio, ranked #685.
Cetera Advisors first reported a position in EXAS in Q4 2019 and has held it in 13 quarters since. 625 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.
- Cetera Advisors held 39,147 shares of Exact Sciences worth $2.7M as of Q1 2024.
- Cetera Advisors bought 32,821 Exact Sciences shares in Q1 2024, an estimated $2.08M.
- Exact Sciences made up 0.02% of Cetera Advisors's portfolio in Q1 2024, its #685 holding.
- Cetera Advisors first reported a position in Exact Sciences in Q4 2019 and has held it in 13 quarters since.
- 625 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.
Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.